Xero, Pro Medicus, JB Hi-Fi: would I buy these three stocks right now?
Let's see how accurate the saying "don't try to catch the falling knife" applies to these growth stocks: Xero, Pro Medicus and JB Hi-Fi. Am I ready to buy them at current prices?
Paul Rickard has more than 30 years’ experience in financial services and banking, including 20 years with the Commonwealth Bank Group in senior leadership roles. Paul was the founding Managing Director and CEO of CommSec, and was named Australian ‘Stockbroker of the Year’ in 2005. In 2011, Paul teamed up with Peter Switzer and Maureen Jordan to launch the Switzer Report, a newsletter and website for share market investors. A regular commentator in the media, investment advisor and company director, he is also a Non-Executive Director of Tyro Payments Ltd and PEXA Group Limited.
Let's see how accurate the saying "don't try to catch the falling knife" applies to these growth stocks: Xero, Pro Medicus and JB Hi-Fi. Am I ready to buy them at current prices?
I’m rebalancing my portfolio and see there has been a huge increase in the weighting to ‘materials’. Is this normal?; Will the super caps be increasing next year?; Do the brokers see price upside for Life360?; Is it too late to participate in BHP’s dividend re-investment plan and how do I do this?
Despite a soft Wall Street, the Aussie share market surged in February adding more than 4%. Our model portfolios, which are marginally overweight resources, continued to outperform.
If you use a ‘core and satellite’ approach to managing your portfolio, how many stocks go into the ‘core’ and how many stocks go into […]
Among all the companies that reported financial results last week, here are 3 “blue chips” that stood out.
Is the US market now underperforming the rest of the world? Should I be looking at ETFs other than IHVV? If Stokes and his partner are now offering $32.75 for BlueScope, why are the shares trading under $30? How did the brokers react to BHP’s profit report? Is there a single source where dividend amounts, dates and franking advice is easily available?
Is the US market now underperforming the rest of the world? Should I be looking at ETFs other than IHVV? If Stokes and his partner are now offering $32.75 for BlueScope, why are the shares trading under $30? How did the brokers react to BHP’s profit report? Is there a single source where dividend amounts, dates and franking advice is easily available?
Are bad times behind this leading global biotechnology company founded in Australia in 1916?
Are interest rates going up good or bad for the banks? What’s the best 12-month term deposit rate? Following CAR Group’s strong profit result, what do the broker analysts now have as their target price? Is it too late to get out of CBA’s dividend re-investment plan and take the $2.35 dividend in cash instead?
Seven magnificent tech giants have powered the rise of the US stock market. They’re now a tick over a third of the benchmark US S&P 500 index. This year they’re off to a mixed start. If you’re concerned you might have too much exposure to them, here are some index tracking ETFs to consider.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.